A Phase 1 Study of CD38-Bispecific Antibody (XmAb18968) for Patients with Relapsed/Refractory T-Cell Acute Lymphoblastic Leukemia

被引:0
|
作者
Murthy, Guru Subramanian Guru [1 ]
Shah, Bijal D. [2 ]
Duvall, Adam S. [3 ]
Leonard, Jessica T. [4 ]
Badar, Talha [5 ]
Yi, Cecilia Y. Arana [6 ]
Kearl, Tyce [7 ]
Baim, Arielle [8 ]
Harrington, Alexandra M. [8 ]
Szabo, Aniko [8 ]
Atallah, Ehab L. [9 ]
机构
[1] Med Coll Wisconsin, Div Hematol Oncol, Dept Med, Milwaukee, WI USA
[2] H Lee Moffitt Canc Ctr & Res Inst, Dept Malignant Hematol, Tampa, FL USA
[3] Univ Chicago, Dept Med, Chicago, IL USA
[4] Oregon Hlth & Sci Univ, Dept Hematol & Med Oncol, Portland, OR USA
[5] Mayo Clin, Jacksonville, FL USA
[6] Mayo Clin, Hematol Oncol, Scottsdale, AZ USA
[7] Med Coll Wisconsin, Div Hematol Oncol, Milwaukee, WI USA
[8] Med Coll Wisconsin, Milwaukee, WI USA
[9] Med Coll Wisconsin, Div Hematol Oncol, Milwaukee, WI USA
关键词
D O I
10.1182/blood-2023-187468
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页数:4
相关论文
共 50 条
  • [31] Analysis of 60 patients with relapsed or refractory T-cell acute lymphoblastic leukemia and T-cell lymphoblastic lymphoma treated with CD7-targeted chimeric antigen receptor-T cell therapy
    Zhang, Xian
    Yang, Junfang
    Li, Jingjing
    Qiu, Liyuan
    Zhang, Jianping
    Lu, Yue
    Zhao, Yan-li
    Jin, David
    Li, Jianqiang
    Lu, Peihua
    AMERICAN JOURNAL OF HEMATOLOGY, 2023, 98 (12) : 1898 - 1908
  • [32] Anti-CD19 CAR T-cell therapy post antibody treatment in adult patients with relapsed/refractory precursor B-acute lymphoblastic leukemia
    Danylesko, Ivetta
    Besser, Michal
    Jacoby, Elad
    Itzhaki, Orit
    Shem-Tov, Noga
    Yerushalmi, Ronit
    Toren, Amos
    Shimoni, Avichai
    Nagler, Arnon
    Avigdor, Abraham
    BONE MARROW TRANSPLANTATION, 2019, 54 : 517 - 518
  • [33] Clinical Experience With Venetoclax Combined With Chemotherapy for Relapsed or Refractory T-Cell Acute Lymphoblastic Leukemia
    Richard-Carpentier, Guillaume
    Jabbour, Elias
    Short, Nicholas J.
    Rausch, Caitlin R.
    Savoy, Jonathan M.
    Bose, Prithviraj
    Yilmaz, Musa
    Jain, Nitin
    Borthakur, Gautam
    Ohanian, Maro
    Alvarado, Yesid
    Rytting, Michael
    Kebriaei, Partow
    Konopleva, Marina
    Kantarjian, Hagop
    Ravandi, Farhad
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2020, 20 (04): : 212 - 218
  • [34] CAG regimen for refractory or relapsed adult T-cell acute lymphoblastic leukemia: A retrospective, multicenter, cohort study
    Qian, Jie-Jing
    Hu, Xiaoxia
    Wang, Ying
    Zhang, Yi
    Du, Juan
    Yang, Min
    Tong, Hongyan
    Qian, Wen-Bin
    Wei, Juying
    Yu, Wenjun
    Lou, Yin-Jun
    Mao, Liping
    Meng, Hai Tao
    You, Liang-Shun
    Wang, Libing
    Li, Xia
    Huang, Xin
    Cao, Li-Hong
    Zhao, Jian-Zhi
    Yan, Xiao Yan
    Chen, Yu-Bao
    Chen, Yu
    Zhang, Su-Jiang
    Jin, Jie
    Hu, Jiong
    Zhu, Hong-Hu
    CANCER MEDICINE, 2020, 9 (15): : 5327 - 5334
  • [35] A Phase 1 First-in-Human Study of AMG 330, an Anti-CD33 Bispecific T-Cell Engager (BiTE®) Antibody Construct, in Relapsed/Refractory Acute Myeloid Leukemia (R/R AML)
    Ravandi, Farhad
    Stein, Anthony S.
    Kantarjian, Hagop M.
    Walter, Roland B.
    Paschka, Peter
    Jongen-Lavrencic, Mojca
    Ossenkoppele, Gert J.
    Yang, Zhao
    Mehta, Bhakti
    Subklewe, Marion
    BLOOD, 2018, 132
  • [36] CD38 as a therapeutic target for adult acute myeloid leukemia and T-cell acute lymphoblastic leukemia
    Naik, Jyoti
    Themeli, Maria
    de Jong-Korlaar, Regina
    Ruiter, Ruud W. J.
    Poddighe, Pino J.
    Yuan, Huipin
    Bruijn, Joost D. d.
    Ossenkoppele, Gert J.
    Zweegman, Sonja
    Smit, Linda
    Mutis, Tuna
    Martens, Anton C. M.
    de Donk, Niels W. C. J. van
    Groen, Richard W. J.
    HAEMATOLOGICA, 2019, 104 (03) : E100 - E103
  • [37] Phase II study of clofarabine in pediatric patients with refractory or relapsed acute lymphoblastic leukemia
    Jeha, S
    Gaynon, PS
    Razzouk, BI
    Franklin, J
    Kadota, R
    Shen, V
    Litchtman-Jones, L
    Rytting, M
    Bomgaars, LR
    Rheingold, S
    Ritchey, K
    Albano, E
    Arceci, RJ
    Goldman, S
    Griffin, T
    Altman, A
    Gordon, B
    Steinherz, L
    Weitman, S
    Steinherz, P
    JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (12) : 1917 - 1923
  • [38] A phase 2 and pharmacological study of sapanisertib in patients with relapsed and/or refractory acute lymphoblastic leukemia
    Al-Kali, Aref
    Aldoss, Ibrahim
    Atherton, Pamela J.
    Strand, Carrie A.
    Shah, Bijal
    Webster, Jonathan
    Bhatnagar, Bhavana
    Flatten, Karen S.
    Peterson, Kevin L.
    Schneider, Paula A.
    Buhrow, Sarah A.
    Kong, Jianping
    Reid, Joel M.
    Adjei, Alex A.
    Kaufmann, Scott H.
    CANCER MEDICINE, 2023, 12 (23): : 21229 - 21239
  • [39] Comparison of Acute Kidney Injury in Patients with Relapsed or Refractory Multiple Myeloma Following CAR T-Cell and Bispecific Antibody Therapies
    Nishimura, Noriko
    Mailankody, Sham
    Nemirovsky, David
    Derkach, Andriy
    Costa, Bruno Almeida
    Farzana, Tasmin
    Shaikh, Aisha
    Latcha, Sheron
    Gutgarts, Victoria
    Jurgens, Eric M.
    Firestone, Ross S.
    Nath, Karthik
    Chung, David J.
    Landau, Heather J.
    Scordo, Michael
    Shah, Gunjan L.
    Shouval, Roni
    Hashmi, Hamza
    Hultcrantz, Malin
    Korde, Neha
    Lesokhin, Alexander M.
    Shah, Urvi A.
    Tan, Carlyn Rose
    Giralt, Sergio A.
    Usmani, Saad Z.
    Rajeeve, Sridevi
    BLOOD, 2024, 144 : 6944 - 6945
  • [40] A Phase 1/2 Study Of Blinatumomab In Pediatric Patients With Relapsed/Refractory B-Cell Precursor Acute Lymphoblastic Leukemia
    von Stackelberd, Arend
    Zugmaier, Gerhard
    Handgretinger, Rupert
    Locatelli, Franco
    Rizzari, Carmelo
    Trippett, Tanya M.
    Borkhardt, Arndt
    Rheingold, Susan R.
    Bader, Peter
    Bhojwani, Deepa
    Cooper, Todd Michael
    DuBois, Steven G.
    O'Brien, Maureen M.
    Zwaan, Christian M.
    Holland, Chris
    Mergen, Noemi
    Fischer, Anja
    Zhu, Min
    Hijazi, Youssef
    Whitlock, James
    Gore, Lia
    BLOOD, 2013, 122 (21)